Antares Pharma, Inc. (ATRS)

Operating Income Growth

179.14%

TTM · Period ending:

ATRS logo

ATRS Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported179.14%
ATRS TTM Operating Income YoY % (-122.55% → 179.14%)
High-resolution chart · PNG

ATRS operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Antares Pharma, Inc. Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
179.1423%
379.088%
100.4966%
161.2736%
342.7765%
1,272.8831%
491.4144%
908.5814%
232.8811%
124.1892%
114.8436%
93.8255%
79.9817%
75.0714%
10.4625%
-3.666%
18.2769%
31.7852%
36.8996%
31.429%
1.1857%
-17.8599%
-9.8982%
-2.3675%
35.1583%
41.7258%
22.5952%
15.8812%
-25.8672%
-68.4065%
-55.5071%
-76.723%
-77.9093%
-82.075%
-203.6582%
-296.1086%
-372.6533%
-158.1034%
-19.4382%
26.8213%
46.6555%
26.3782%
24.4551%
28.3104%
33.0213%
37.8308%
25.8392%
19.583%
22.773%
20.5307%
23.8292%
18.482%
2.4804%
-41.089%
-91.2395%
-107.617%
-80.8898%
-4.4553%
23.7644%
31.58%
25.5329%
3.6365%
4.4424%
6.8596%
2.6994%
-2.5614%
-10.2936%
-11.6819%
-3.6592%
3.0041%
18.8491%
14.6728%
14.7552%
15.8631%
-15.5368%
-8.7357%
-10.5869%
-20.2624%
-16.9712%
-38.4869%
-56.2707%
-70.457%
-107.3022%
-75.4926%
-54.52%
-55.8999%
26.8829%
28.1914%
31.1047%
47.7536%
-19.0076%
-33.1456%
-45.6135%
-78.6619%
-26.7279%
-38.4523%
-41.3591%
-122.5494%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.